Does TOBRAMYCIN Cause Increased bronchial secretion? 37 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 37 reports of Increased bronchial secretion have been filed in association with TOBRAMYCIN (TOBRAMYCIN). This represents 0.3% of all adverse event reports for TOBRAMYCIN.
37
Reports of Increased bronchial secretion with TOBRAMYCIN
0.3%
of all TOBRAMYCIN reports
2
Deaths
26
Hospitalizations
How Dangerous Is Increased bronchial secretion From TOBRAMYCIN?
Of the 37 reports, 2 (5.4%) resulted in death, 26 (70.3%) required hospitalization.
Is Increased bronchial secretion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOBRAMYCIN. However, 37 reports have been filed with the FAERS database.
What Other Side Effects Does TOBRAMYCIN Cause?
Off label use (1,467)
Death (888)
Cough (738)
Dyspnoea (706)
Pneumonia (700)
Hospitalisation (688)
Condition aggravated (669)
Cystic fibrosis (646)
Infective pulmonary exacerbation of cystic fibrosis (504)
Drug ineffective (453)
What Other Drugs Cause Increased bronchial secretion?
ALBUTEROL (637)
OMALIZUMAB (144)
MEPOLIZUMAB (119)
FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE (93)
FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (87)
FLUTICASONE\SALMETEROL (86)
FLUTICASONE (82)
PREDNISONE (74)
TIOTROPIUM (65)
BUDESONIDE\FORMOTEROL (63)
Which TOBRAMYCIN Alternatives Have Lower Increased bronchial secretion Risk?
TOBRAMYCIN vs TOBRAMYCIN\TOBRAMYCIN
TOBRAMYCIN vs TOCILIZUMAB
TOBRAMYCIN vs TOCILIZUMAB-AAZG
TOBRAMYCIN vs TOCOPHEROL
TOBRAMYCIN vs TOFACITINIB